Skip to main content
Livermore
Livermore
ZHEN

Morgan Stanley

SEC CIK
0000895421
Latest filing
Aug 13, 2026

DAWN holding history

Day One Biopharmaceuticals, Inc. in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DAWN overviewAll 13F holders of DAWNFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
20
Since Q2 2021
Holdings of DAWN by Morgan Stanley, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−687,107−100.0%Sold outHolders
Q1 2026687,107$14.7M<0.1%−863,167−55.7%ReducedHolders
Q4 20251,550,274$14.4M<0.1%+246,245+18.9%AddedHolders
Q3 20251,304,029$9.19M<0.1%−49,119−3.6%ReducedHolders
Q2 20251,353,148$8.80M<0.1%+643,733+90.7%AddedHolders
Q1 2025709,415$5.63M<0.1%−370,853−34.3%ReducedHolders
Q4 20241,080,268$13.7M<0.1%+305,757+39.5%AddedHolders
Q3 2024774,511$10.8M<0.1%+607,265+363.1%AddedHolders
Q2 2024167,246$2.30M<0.1%−65,304−28.1%ReducedHolders
Q1 2024232,550$3.84M<0.1%−101,889−30.5%ReducedHolders
Q4 2023334,439$4.88M<0.1%+175,993+111.1%AddedHolders
Q3 2023158,446$1.94M<0.1%−79,258−33.3%ReducedHolders
Q2 2023237,704$2.84M<0.1%+53,785+29.2%AddedHolders
Q1 2023183,919$2.46M<0.1%+96,654+110.8%AddedHolders
Q4 202287,265$1.88M<0.1%−20,140−18.8%ReducedHolders
Q3 2022107,405$2.15M<0.1%+70,365+190.0%AddedHolders
Q2 202237,040$662.0K<0.1%+20,587+125.1%AddedHolders
Q1 202216,453$162.0K<0.1%+2,489+17.8%AddedHolders
Q4 202113,964$236.0K<0.1%+10,997+370.6%AddedHolders
Q3 20212,967$70.0K<0.1%+593+25.0%AddedHolders
Q2 20212,374$54.0K<0.1%+2,374NewHolders